Medically reviewed by Renita White, MD BRCA testing helps determine if you have a gene mutation that increases your cancer ...

The current testing rate for BRCA 1/2 mutations is currently 68% in HER2-negative early breast cancer, but eligible patients could receive better care if tested. The current rate of BRCA1/2 testing ...

In late December of 2013, the US Preventive Services Task Force (USPSTF) provided an update to its 2005 recommendations, reaffirming the genetic risk assessment and breast cancer susceptibility gene ...

Breast cancer awareness month marks a great time to brush up on your knowledge regarding the importance of BRCA gene testing. BRCA gene testing scans the body for mutations in both the BRCA1 and BRCA2 ...

Harmful variants in the BRCA1 gene greatly increase a person's lifetime risk of developing breast, ovarian and pancreatic cancers, but most people are unaware they are carriers. In a new study in the ...

About 1 in 8 women will be diagnosed with breast cancer in her lifetime. But the proportion who develop the common cancer as a result of a genetic mutation — namely to the BRCA1 or BRCA2 genes — is ...

ROANOKE, Va. – It’s estimated that more than 42,000 people will die from breast cancer this year, according to the American Cancer Society. To help you understand if you’re at a greater risk of ...

Using current treatment costs and medical guidelines, genetic testing for BRCA1/2 mutations among apparently healthy women at high risk of breast and/or ovarian cancer was deemed cost-effective in a ...

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

In May 2013, nearly 20 years after the discovery that mutations on the BRCA1 and BRCA2 genes could lead to a higher risk of breast and ovarian cancer, A-list Hollywood actress Angelina Jolie garnered ...

Not only do home genetic test kits, like 23andMe, provide information about your ancestry, but they can also give you some insights into your inherited health risks, particularly mutations on the BRCA ...

Lynparza significantly improves iDFS, DDFS, and OS in BRCA1/2 mutation-positive, HER2-negative high-risk breast cancer patients. The trial's six-year analysis shows consistent benefits across all ...